GFAP Complements NfL as a Multiple Sclerosis Biomarker : vim

Although serum glial fibrillary acid protein (GFAP) could be a useful complement to the multiple sclerosis biomarker neurofilament light chain (NfL), it is not ready for the clinic, experts say.

Related Keywords

Switzerland , Amsterdam , Noord Holland , Netherlands , Viela Bio , Stephanie Meier , Elias Sotirchos , Genentech , Amsterdam University Medical Center , Research In Multiple Sclerosis , University Of Basel , European Committee For Treatment , European Committee , Multiple Sclerosis , Nfl May Be Complementary Biomarkers , Amsterdam University Medical , Johns Hopkins Medicine , Horizon Therapeutics , Multiple Sclerosis Ms , Us , Biomarker , Iological Marker , Activism , Activist , Social Issues , Disability , Magnetic Resonance Imaging Mri , Magnetic Resonance Imaging , Ri , Maging Magnetic Resonance , Ms Lesion , Ultiple Sclerosis Lesion , Multiple Sclerosis Relapse , S Relapse , Elapse Of Multiple Sclerosis , Elapse Of Ms , Relapsing Remitting Multiple Sclerosis , Arms , Ultiple Sclero ,